Literature DB >> 26455791

[Prevalence and prognostic meaning of comorbidity in heart failure].

A Conde-Martel1, M Hernández-Meneses2.   

Abstract

Heart failure (HF) predominantly affects elderly individuals and has a significant impact on the health systems of developed countries. Comorbidities are present in most patients with HF by acting as the cause, the consequence or a mere coincidence. In addition to their high prevalence, they have considerable relevance because they can mask symptoms, impede the diagnosis and treatment, contribute to progression and negatively influence the prognosis of HF. Most of the associated comorbidities result in a greater number of hospitalisations, poorer quality of life and increased mortality. Given that many of these comorbidities are underdiagnosed, their detection could improve the outcome and quality of life of patients with HF. This article reviews the prevalence and prognostic meaning of the most prevalent comorbidities associated with HF.
Copyright © 2015 Elsevier España, S.L.U. y Sociedad Española de Medicina Interna (SEMI). All rights reserved.

Entities:  

Keywords:  Comorbidity; Comorbilidad; Heart failure; Insuficiencia cardiaca; Prevalence; Prevalencia; Prognosis; Pronóstico

Year:  2015        PMID: 26455791     DOI: 10.1016/j.rce.2015.08.005

Source DB:  PubMed          Journal:  Rev Clin Esp (Barc)        ISSN: 2254-8874


  5 in total

Review 1.  Efficacy of tolvaptan for chronic heart failure: Study protocol for a systematic review of randomized controlled trial.

Authors:  Wei-Qin Gao; Xiang-Dong Meng; Ze Sun
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

2.  Prognostic Significance of the PROFUND Index on One Year Mortality in Acute Heart Failure: Results from the RICA Registry.

Authors:  Manuel Méndez-Bailon; Rosario Iguarán-Bermudez; Francesc Formiga-Pérez; José Carlos Arévalo Lorido; Iván Suárez-Pedreira; Jose Luis Morales-Rull; Ana Serrado-Iglesias; Pau Llacer-Iborra; Gabriela Ormaechea-Gorricho; Francisco Javier Carrasco-Sánchez; Jesús Casado-Cerrada; Emmanuel Andrès; Jesús Diez-Manglano; Noel Lorenzo-Villalba; Manuel Montero-Pérez-Barquero
Journal:  J Clin Med       Date:  2022-03-28       Impact factor: 4.241

3.  Prognostic Significance of Lung and Cava Vein Ultrasound in Elderly Patients Admitted for Acute Heart Failure: PROFUND-IC Registry Analysis.

Authors:  Sara Pérez-Herrero; Noel Lorenzo-Villalba; Elena Urbano; Beatriz Sánchez-Sauce; Fernando Aguilar-Rodríguez; Máximo Bernabeu-Wittel; Rocio Garcia-Alonso; Llanos Soler-Rangel; Francisco Trapiello-Valbuena; Alejandra Garcia-García; Jose Manuel Casas-Rojo; Luis Beltrán-Romero; Lucia De Jorge-Huerta; Juan Igor Molina-Puente; Emmanuel Andrès; Rosario Iguarán-Bermúdez; Manuel Méndez-Bailón
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

4.  Costs and healthcare utilisation of patients with heart failure in Spain.

Authors:  Carlos Escobar; Luis Varela; Beatriz Palacios; Margarita Capel; Antoni Sicras; Aram Sicras; Antonio Hormigo; Roberto Alcázar; Nicolás Manito; Manuel Botana
Journal:  BMC Health Serv Res       Date:  2020-10-20       Impact factor: 2.655

5.  Waist to height ratio is associated with an increased risk of mortality in Chinese patients with heart failure with preserved ejection fraction.

Authors:  Jianqiao Chen; Man Li; Benchuan Hao; Yulun Cai; Huiying Li; Wenli Zhou; Yujian Song; Shiqi Wang; Hongbin Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-05-28       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.